Determination of celecoxib in human plasma by normal-phase high-performance liquid chromatography with column switching and ultraviolet absorbance detection
Mj. Rose et al., Determination of celecoxib in human plasma by normal-phase high-performance liquid chromatography with column switching and ultraviolet absorbance detection, J CHROMAT B, 738(2), 2000, pp. 377-385
A method is described for the determination of celecoxib in human plasma. S
amples were extracted using 3M Empore membrane extraction cartridges and se
parated under normal-phase HPLC conditions using a Nucleosil-NO2 (150x4.6 m
m, 5 mu m) column. Detection was accomplished using UV absorbance at 260 nm
. The HPLC method included a column switching procedure, in which late elut
ing compounds were diverted to waste, to reduce run-time to 12 min. The ass
ay was linear in the concentration range of 25-2000 ng/ml when 1-ml aliquot
s of plasma were extracted. Recoveries of celecoxib were greater than 91% o
ver the calibration curve range. Intraday precision and accuracy for this a
ssay were 5.7% C.V. or better and within 2.3% of nominal, respectively. The
assay was used to analyze samples collected during human clinical studies.
(C) 2000 Elsevier Science B.V. All rights reserved.